Correlation Between Immutep and NervGen Pharma

Can any of the company-specific risk be diversified away by investing in both Immutep and NervGen Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immutep and NervGen Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Immutep Ltd ADR and NervGen Pharma Corp, you can compare the effects of market volatilities on Immutep and NervGen Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immutep with a short position of NervGen Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immutep and NervGen Pharma.

Diversification Opportunities for Immutep and NervGen Pharma

0.72

Correlation Coefficient

Immutep  NervGen Pharma

Poor diversification

The 3 months correlation between Immutep and NervGen is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Immutep Ltd ADR and NervGen Pharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NervGen Pharma Corp and Immutep is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immutep Ltd ADR are associated (or correlated) with NervGen Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NervGen Pharma Corp has no effect on the direction of Immutep i.e., Immutep and NervGen Pharma go up and down completely randomly.

Pair Corralation between Immutep and NervGen Pharma

Given the investment horizon of 90 days Immutep Ltd ADR is expected to generate 1.2 times more return on investment than NervGen Pharma. However, Immutep is 1.2 times more volatile than NervGen Pharma Corp. It trades about -0.07 of its potential returns per unit of risk. NervGen Pharma Corp is currently generating about -0.13 per unit of risk. If you would invest  208.00  in Immutep Ltd ADR on December 30, 2024 and sell it today you would lose (22.00) from holding Immutep Ltd ADR or give up 10.58% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Immutep Ltd ADR  vs.  NervGen Pharma Corp

Immutep Ltd ADR

Risk-Adjusted Performance

Very Weak

Over the last 90 days Immutep Ltd ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's primary indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

NervGen Pharma Corp

Risk-Adjusted Performance

Very Weak

Over the last 90 days NervGen Pharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Immutep and NervGen Pharma

The main advantage of trading using opposite Immutep and NervGen Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immutep position performs unexpectedly, NervGen Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NervGen Pharma will offset losses from the drop in NervGen Pharma's long position.

The idea behind Immutep Ltd ADR and NervGen Pharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.